Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances

Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality worldwide. HCC is an inflammation-associated immunogenic cancer that frequently arises in chronically inflamed livers. Advanced HCC is managed with systemic therapies; the tyrosine kinase inhibitor (TKI) sorafenib has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Rallis, Kathrine S, Makrakis, Dimitrios, Ziogas, Ioannis A, Tsoulfas, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244967/
https://www.ncbi.nlm.nih.gov/pubmed/35949435
http://dx.doi.org/10.5306/wjco.v13.i6.448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244967/
https://www.ncbi.nlm.nih.gov/pubmed/35949435
http://dx.doi.org/10.5306/wjco.v13.i6.448

Ejemplares similares